Emergent has entered a strategic financial investment agreement with Swiss Rockets to support the latter’s biotech portfolio.

Telix states its automated and high-throughput generator can produce sufficient lead-212 elution for up to 60 clinical doses, ...

Vivace Therapeutics has closed $35m in a Series D financing round to support the clinical development of its cancer drug ...

Silgan Dispensing creates dispensing solutions for some of the world’s most iconic brands—from triggers and pumps to sprayers and closures. But more than that, we create better experiences for both ...

Atsena Therapeutics has received fast track designation from the FDA for ATSN-201, aimed at treating X-linked retinoschisis ...

Europe’s drug regulatory agency has given Kizfizo a negative opinion for the second time, following one from November 2024.

Ono Pharmaceuticals has secured the global rights to sapablursen, an RNA-targeting therapy by Ionis to treat polycythemia ...

The specialist in temperature-sensitive pharmaceutical shipments, is introducing the industry’s most comprehensive cold chain ...

Vori Health has secured $53m in a Series B funding round, supporting its value-based musculoskeletal care offerings in the US ...

The two companies will work together on Zealand’s amylin analogue petrelintide as a monotherapy and in combination therapies.

Entos Pharmaceuticals has announced an investment of C$62m ($43.05m) from the governments of Canada and Alberta for an R&D facility.

WuXi XDC Cayman has signed a memorandum of understanding (MoU) with South Korea-based AbTis to advance next-generation ADCs.